1977
DOI: 10.1001/archderm.1977.01640070121036
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Mycobacterium marinum Infections With Minocycline

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1980
1980
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…Erythromycin was slightly less inhibitory than the tetracyclines and TMP-S. Although tetracyclines were clinically effective (5,9,(12)(13)(14), two studies noted in vitro resistance of M. marinum to tetracycline at 100 jig/ml (12) and 25 to 50,ug/ml (9). Because these concentrations greatly exceeded the usual achievable blood levels (3 to 6 ,ug/ml), the therapeutic effect was considered by one author to be on a basis other than antibacterial activity (16).…”
Section: Resultsmentioning
confidence: 99%
“…Erythromycin was slightly less inhibitory than the tetracyclines and TMP-S. Although tetracyclines were clinically effective (5,9,(12)(13)(14), two studies noted in vitro resistance of M. marinum to tetracycline at 100 jig/ml (12) and 25 to 50,ug/ml (9). Because these concentrations greatly exceeded the usual achievable blood levels (3 to 6 ,ug/ml), the therapeutic effect was considered by one author to be on a basis other than antibacterial activity (16).…”
Section: Resultsmentioning
confidence: 99%
“…1), first synthesized in 1967, is a semi-synthetic second-generation tetracycline derivative (Qiu et al 2019). Many pathogenic mycoplasmas, chlamydias, spirochetes, rickettsias, and enterococci such as Borrelia recurrentis, Mycobacterium marinum, Mycoplasma pneumoniae, and Vibrio vulnificus are susceptible to MC (Chuang et al 1997, Lockshin 1977, Muellegger et al 1995, Rose and Vanderloo 2011 .…”
Section: Introductionmentioning
confidence: 99%